A Virtual Reality View: Understanding, Recognizing, and Managing Rett Syndrome
Released On
August 18, 2023
Expires On
August 18, 2024
Media Type
Internet
Completion Time
30 minutes
Specialty
Case Management, Education, Genetics, Hospitalist, Neurology, Integrative Medicine, Neonatology, Pediatrics, Pharmacy, Primary Care, Pulmonology, Sleep Medicine
Topic(s)
Pediatrics, Pharmacology, Mental Health, Nutrition, Respiratory, Sleep Medicine
This activity is provided by Med Learning Group.
This activity is co-provided by AMEDCO
Nursing learners, view this Learner Notification prior to starting this activity
This activity is supported by an educational grant from Acadia Pharmaceuticals Inc.
Credit Available
- Physicians — maximum of 0.50 AMA PRA Category 1 Credit™
- Nurses — 0.50 ANCC Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is intended for pediatric neurologists and neurologists involved in the diagnosis and treatment of RTT.
Program Overview
This educational enduring activity focuses on the key characteristics and management strategies of Rett Syndrome (RTT). Learn more about the genetic underpinnings and pathophysiology of RTT, distinctive clinical manifestations to aid diagnosis, and new therapeutic options that may help improve the disease burden of RTT. Through expert case study presentation, learners will be guided on ways to incorporate strategies for providing a timely and accurate diagnosis of RTT into clinical practice, as well as to evaluate the clinical profiles of approved and emerging therapeutic options for treatment of RTT.
Learning Objectives
- Upon completion of this activity, participants should be able to:
- Explain key characteristics of RTT, including its genetic underpinnings, pathophysiology, clinical manifestations, complications, burdens, and associated negative outcomes
- Incorporate strategies for providing a timely and accurate diagnosis of RTT into clinical practice
- Evaluate the clinical profiles of newly approved therapeutic options for RTT
Faculty
Alan K. Percy, MD
Program Chair & Faculty Presenter
Professor Emeritus
Sarah Katherine Bateh Professor for Rett Syndrome
Division of Pediatric Neurology
University of Alabama at Birmingham
Birmingham, AL
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™ Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nursing Continuing Education Credit Designation
Amedco LLC designates this activity for a maximum of 0.50 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Relevant Financial Relationship(s)
- Alan K. Percy, MD
- Consultant fees: Acadia Pharmaceuticals, Taysha Gene Therapies, and Neurogene
- Contracted Research: Site PI for clinical trial, Acadia Pharmaceuticals
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity::
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Nicole Longo, DO, FACOI, VP of Med/Sci Services & Learner Engagement for Med Learning Group, has nothing to disclose.
Payal Patel, PharmD, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose.
Laura Aibara, Program Coordinator, for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
Method of Participation
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com
Content - Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
